p.26 抽出テキスト
Circulation. 2025;152(suppl 2):S538–S577. DOI: 10.1161/CIR.0000000000001376 October 21, 2025 S563 Wigginton et al Advanced Life Support: 2025 AHA Guidelines for CPR and ECC HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm. 2018;15:e73– e189. doi: 10.1016/j.hrthm.2017.10.036 3. Roth A, Elkayam I, Shapira I, Sander J, Malov N, Kehati M, Golovner M. Effectiveness of prehospital synchronous direct-current cardioversion for supraventricular tachyarrhythmias causing unstable hemodynamic states. Am J Cardiol. 2003;91:489–491. doi: 10.1016/s0002-9149(02)03257-5 4. Josephson ME. Lidocaine and sustained monomorphic ventricular tachycardia: fact or fiction. Am J Cardiol. 1996;78:82–83. doi: 10.1016/s0002-9149(96)00271-8 5. Somberg JC, Bailin SJ, Haffajee CI, Paladino WP, Kerin NZ, Bridges D, Timar S, Molnar J, Amio-Aqueous I. Intravenous lidocaine versus intravenous amiodarone (in a new aqueous formulation) for incessant ventricular tachycardia. Am J Cardiol. 2002;90:853–859. doi: 10.1016/s0002-9149(02)02707-8 6. Ortiz M, Martin A, Arribas F, Coll-Vinent B, Del Arco C, Peinado R, Almendral J; Investigators PS. Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study. Eur Heart J. 2017;38:1329–1335. doi: 10.1093/eurheartj/ehw230 7. Ho DS, Zecchin RP, Richards DA, Uther JB, Ross DL. Double-blind trial of lignocaine versus sotalol for acute termination of spontaneous sustained ventricular tachycardia. Lancet. 1994;344:18–23. doi: 10.1016/s0140-6736(94)91048-0 8. Gorgels AP, van den Dool A, Hofs A, Mulleneers R, Smeets JL, Vos MA, Wellens HJ. Comparison of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia. Am J Cardiol. 1996;78:43–46. doi: 10.1016/s0002-9149(96)00224-x 9. deSouza IS, Martindale JL, Sinert R. Antidysrhythmic drug therapy for the termination of stable, monomorphic ventricular tachycardia: a systematic review. Emerg Med J. 2015;32:161–167. doi: 10.1136/emermed-2013-202973 10. Rankin AC, Oldroyd KG, Chong E, Rae AP, Cobbe SM. Value and limitations of adenosine in the diagnosis and treatment of narrow and broad complex tachycardias. Br Heart J. 1989;62:195–203. doi: 10.1136/hrt.62.3.195 11. Marill KA, Wolfram S, Desouza IS, Nishijima DK, Kay D, Setnik GS, Stair TO, Ellinor PT. Adenosine for wide-complex tachycardia: efficacy and safety. Crit Care Med. 2009;37:2512–2518. doi: 10.1097/CCM.0b013e3181a93661 12. Stewart RB, Bardy GH, Greene HL. Wide complex tachycardia: misdiagnosis and outcome after emergent therapy. Ann Intern Med. 1986;104:766– 771. doi: 10.7326/0003-4819-104-6-766 13. Buxton AE, Marchlinski FE, Doherty JU, Flores B, Josephson ME. Hazards of intravenous verapamil for sustained ventricular tachycardia. Am J Cardiol. 1987;59:1107–1110. doi: 10.1016/0002-9149(87)90857-5 14. Gupta AK, Shah CP, Maheshwari A, Thakur RK, Hayes OW, Lokhandwala YY. Adenosine induced ventricular fibrillation in Wolff-Parkinson- White syndrome. Pacing Clin Electrophysiol. 2002;25:477–480. doi: 10.1046/j.1460-9592.2002.00477.x Figure 6. Adult Tachyarrhythmia With a Pulse Algorithm. CHF indicates congestive heart failure; ECG, electrocardiogram; IV, intravenous; NS, normal saline; and VT, ventricular tachycardia. Downloaded from http://ahajournals.org by on October 7, 2026